Investment Thesis
What this tool is for, who it's for, and the philosophy it runs on. It is not a trading signal, a hot-stock tipsheet, or a promise. It is a disciplined way to ask one question of all 503 S&P 500 companies at once: what is this business worth, and am I being offered it for less?
The north star
Own good businesses bought below what they're worth, and over the long run beat simply holding the S&P 500 index fund. Not next week — over years. We'd rather be roughly right about value and patient than precisely wrong about timing.
What we believe
Price and value are different things
The market quotes a price every second; it tells you almost nothing about what a business is worth. Value comes from the cash a company will generate over its life. We estimate that value from fundamentals — cash flows, earnings power, balance-sheet strength — and compare it to the price. The gap is the opportunity.
Margin of safety over precision
Every valuation is an estimate, and estimates are wrong. So we don't buy at fair value — we look to buy at a discount to it. The discount absorbs our errors and the future's surprises. A cheap price for a good business is the closest thing to a free lunch in investing.
Quality first, then price
A cheap bad business is usually just a value trap. We screen for durable economics — businesses that earn good returns, don't drown in debt, and can keep doing so. Then we ask whether the price is attractive. A wonderful business at a fair price beats a fair business at a wonderful price.
Multiple lenses, not one magic number
No single model captures a business. We triangulate intrinsic value from several independent methods and trust a recommendation more when they agree. When they disagree, that disagreement is itself information — and a reason for caution.
Being early is not the same as being wrong
The hardest part of value investing is that the market can stay irrational longer than feels comfortable. A cheap stock can get cheaper before it's recognized. We accept being early — holding a sound position through a stretch of being "wrong" — because the alternative, chasing what's already popular, is how you buy high. Our edge is patience, not prediction.
Measured honestly, in public
A thesis is worthless if you can't tell whether it works. Every recommendation is timestamped and scored against the index it's trying to beat — win or lose. See the track record.
On today's market
We may well be in a bubble. Valuations across much of the index are stretched by historical standards, and a broad correction wouldn't surprise us. But "the market is expensive" is not the same as "there is nothing worth buying." Markets are made of 503 different businesses, not one — and even in a frothy tape there are always names the crowd has overlooked, mispriced, or thrown out with the sector. Our job isn't to time the index; it's to find those specific deals, demand a margin of safety big enough to survive a downturn, and wait. If the whole market corrects, the businesses we bought cheaply with a cushion are the ones best positioned to come through it.
How we decide — our investment committee
No single lens gets a stock right. Every name our model rates is argued by a standing panel of perspectives — the same tensions great investors have debated for decades. Each one asks a different question, and the disagreement between them is the point: it shows exactly which assumption a verdict depends on. When they split, we say so.
The Owner
in the spirit of Warren Buffett
“What is this business worth, and is there a margin of safety?”
Values the company on the cash it will return to owners over a decade, and refuses to pay up — demands a discount to intrinsic value before buying.
The Quality Analyst
in the spirit of Charlie Munger
“Will the economics still be here in ten years?”
Judges durability — returns on capital, balance-sheet strength, and whether the moat is real and lasting or just one good year. Vetoes value traps.
The Innovator
in the spirit of Philip Fisher
“Is it building durable growth — or chasing a trend?”
Looks at what the company is building — R&D, reinvestment, platform positioning — to underwrite a long-term growth runway, grounded in facts rather than hype.
The Contrarian
in the spirit of Howard Marks
“Is the crowd mispricing it — and can it survive being early?”
Hunts the names others are forced or frightened to sell, but demands a tangible-asset floor and the balance sheet to endure until the market agrees.
The Skeptic
in the spirit of Jim Chanos
“What kills this thesis?”
The designated adversary. Defaults to 'avoid' and attacks the bull case — flattered cash flow, growth already in the price, debt, a number too good to be true.
The Macro Strategist
in the spirit of Ray Dalio
“What regime are we in?”
Reads the weather — rates, the cycle, which sectors are euphoric vs hated — and widens the required margin of safety when the whole market is stretched.
The Chair
in the spirit of Benjamin Graham
“Given all of that, do we act?”
Weighs the panel rather than averaging it, decides, and names the single biggest risk and the assumption the position rides on. Reports split votes honestly.
What this is not
- — Not a short-term trading signal or a momentum tool.
- — Not a guarantee. We will be wrong on individual names, sometimes for a long time.
- — Not financial advice. It's a personal research tool, shared openly.
- — Not a black box you should follow blindly — do your own work before risking your money.
The specific models, weightings, and thresholds behind the numbers are proprietary. The philosophy above is not — it's the standard we hold ourselves to. Personal analysis tool, not financial advice.